Long-Term Outcomes of Partial Oral Treatment of Endocarditis

Henning Bundgaard; Nikolaj Ihlemann; Sabine U Gill; Niels E Bruun; Hanne Elming; Trine Madsen; Kaare T Jensen; Kurt Fursted; Jens J Christensen; Martin Schultz; Lauge Østergaard; Flemming Rosenvinge; Henrik C Schønheyder; Jannik Helweg-Larsen; Emil L Fosbøll; Lars Køber; Christian Torp-Pedersen; Niels Tønder; Claus Moser; Kasper Iversen

doi:10.1056/nejmc1902096

Long-Term Outcomes of Partial Oral Treatment of Endocarditis

Henning Bundgaard, Nikolaj Ihlemann, Sabine U Gill, Niels E Bruun, Hanne Elming, Trine Madsen, Kaare T Jensen, Kurt Fursted, Jens J Christensen, Martin Schultz, Lauge Østergaard, Flemming Rosenvinge, Henrik C Schønheyder, Jannik Helweg-Larsen, Emil L Fosbøll, Lars Køber, Christian Torp-Pedersen, Niels Tønder, Claus Moser, Kasper Iversen

13 Citations (Scopus)

Original language	English
Journal	The New England Journal of Medicine
Volume	380
Issue number	14
Pages (from-to)	1373-1374
Number of pages	2
ISSN	0028-4793
DOIs	https://doi.org/10.1056/nejmc1902096
Publication status	Published - 4 Apr 2019

Keywords

Administration, Intravenous
Administration, Oral
Anti-Bacterial Agents/administration & dosage
Endocarditis, Bacterial/drug therapy
Follow-Up Studies
Humans
Recurrence

Access to Document

10.1056/nejmc1902096

Cite this

Bundgaard, H., Ihlemann, N., Gill, S. U., Bruun, N. E., Elming, H., Madsen, T., Jensen, K. T., Fursted, K., Christensen, J. J., Schultz, M., Østergaard, L., Rosenvinge, F., Schønheyder, H. C., Helweg-Larsen, J., Fosbøll, E. L., Køber, L., Torp-Pedersen, C., Tønder, N., Moser, C., & Iversen, K. (2019). Long-Term Outcomes of Partial Oral Treatment of Endocarditis. The New England Journal of Medicine, 380(14), 1373-1374. https://doi.org/10.1056/nejmc1902096

Bundgaard, H, Ihlemann, N, Gill, SU, Bruun, NE, Elming, H, Madsen, T, Jensen, KT, Fursted, K, Christensen, JJ, Schultz, M, Østergaard, L, Rosenvinge, F, Schønheyder, HC, Helweg-Larsen, J, Fosbøll, EL, Køber, L , Torp-Pedersen, C, Tønder, N, Moser, C & Iversen, K 2019, 'Long-Term Outcomes of Partial Oral Treatment of Endocarditis', The New England Journal of Medicine, vol. 380, no. 14, pp. 1373-1374. https://doi.org/10.1056/nejmc1902096

@article{b6236c3f52554ed0bc80c06dcc44fe81,

title = "Long-Term Outcomes of Partial Oral Treatment of Endocarditis",

keywords = "Administration, Intravenous, Administration, Oral, Anti-Bacterial Agents/administration & dosage, Endocarditis, Bacterial/drug therapy, Follow-Up Studies, Humans, Recurrence",

author = "Henning Bundgaard and Nikolaj Ihlemann and Gill, {Sabine U} and Bruun, {Niels E} and Hanne Elming and Trine Madsen and Jensen, {Kaare T} and Kurt Fursted and Christensen, {Jens J} and Martin Schultz and Lauge {\O}stergaard and Flemming Rosenvinge and Sch{\o}nheyder, {Henrik C} and Jannik Helweg-Larsen and Fosb{\o}ll, {Emil L} and Lars K{\o}ber and Christian Torp-Pedersen and Niels T{\o}nder and Claus Moser and Kasper Iversen",

year = "2019",

month = apr,

day = "4",

doi = "10.1056/nejmc1902096",

language = "English",

volume = "380",

pages = "1373--1374",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "14",

}

TY - JOUR

T1 - Long-Term Outcomes of Partial Oral Treatment of Endocarditis

AU - Bundgaard, Henning

AU - Ihlemann, Nikolaj

AU - Gill, Sabine U

AU - Bruun, Niels E

AU - Elming, Hanne

AU - Madsen, Trine

AU - Jensen, Kaare T

AU - Fursted, Kurt

AU - Christensen, Jens J

AU - Schultz, Martin

AU - Østergaard, Lauge

AU - Rosenvinge, Flemming

AU - Schønheyder, Henrik C

AU - Helweg-Larsen, Jannik

AU - Fosbøll, Emil L

AU - Køber, Lars

AU - Torp-Pedersen, Christian

AU - Tønder, Niels

AU - Moser, Claus

AU - Iversen, Kasper

PY - 2019/4/4

Y1 - 2019/4/4

KW - Administration, Intravenous

KW - Administration, Oral

KW - Anti-Bacterial Agents/administration & dosage

KW - Endocarditis, Bacterial/drug therapy

KW - Follow-Up Studies

KW - Humans

KW - Recurrence

U2 - 10.1056/nejmc1902096

DO - 10.1056/nejmc1902096

M3 - Journal article

C2 - 30883059

SN - 0028-4793

VL - 380

SP - 1373

EP - 1374

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 14

ER -